Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 17.42
(6.48%)
CNY 17.42
(6.48%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.66 Million CNY | 14.57% |
| 2022 | 1.45 Million CNY | -42.35% |
| 2021 | 2.51 Million CNY | -96.33% |
| 2020 | 68.5 Million CNY | 27.09% |
| 2019 | 53.9 Million CNY | -3.58% |
| 2018 | 55.9 Million CNY | -59.49% |
| 2017 | 138 Million CNY | -33.68% |
| 2016 | 208.06 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 131.25 Million CNY | 106.06% |
| 2024 Q3 | 149.5 Million CNY | -45.39% |
| 2024 Q1 | 63.7 Million CNY | 3734.54% |
| 2023 Q3 | 52.42 Million CNY | 1.8% |
| 2023 Q2 | 51.5 Million CNY | 0.07% |
| 2023 Q1 | 51.46 Million CNY | 3449.38% |
| 2023 FY | 1.66 Million CNY | 14.57% |
| 2023 Q4 | 1.66 Million CNY | -96.83% |
| 2022 Q4 | 1.45 Million CNY | -26.23% |
| 2022 Q3 | 1.96 Million CNY | -8.71% |
| 2022 Q2 | 2.15 Million CNY | -6.42% |
| 2022 Q1 | 2.3 Million CNY | -8.53% |
| 2022 FY | 1.45 Million CNY | -42.35% |
| 2021 Q2 | 42 Million CNY | -30.0% |
| 2021 FY | 2.51 Million CNY | -96.33% |
| 2021 Q1 | 60 Million CNY | -12.41% |
| 2021 Q4 | 2.51 Million CNY | -84.28% |
| 2021 Q3 | 16 Million CNY | -61.9% |
| 2020 Q4 | 68.5 Million CNY | 0.0% |
| 2020 FY | 68.5 Million CNY | 27.09% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | 100.4 Million CNY | 0.0% |
| 2019 Q2 | 46.4 Million CNY | 0.0% |
| 2019 Q4 | 53.9 Million CNY | 0.0% |
| 2019 Q3 | 53.9 Million CNY | 16.16% |
| 2019 FY | 53.9 Million CNY | -3.58% |
| 2019 Q1 | 46.4 Million CNY | 0.0% |
| 2018 FY | 55.9 Million CNY | -59.49% |
| 2017 FY | 138 Million CNY | -33.68% |
| 2016 FY | 208.06 Million CNY | 0.0% |